More recently, we have shown that TRDMT1 KO may modulate chemotherapy-associated responses that affected genetic stability and promoted cellular heterogeneity in stress-induced senescent glioblastoma cells [14]. The gene discussed is TRDMT1; the disease is glioblastoma.